Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-10-13
1994-08-02
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514253, 514357, 514461, 514826, A61K 3155, A61K 3150, A61K 3141, A61K 3134
Patent
active
053345924
ABSTRACT:
Methods and compositions are disclosed employing combinations of antihistamines with certain diaryl tetrahydrofuran, diaryl tetrahydrothiophene, triazolobenzodiazepine or thienotriazolodiazepine PAF-antagonist compounds in the treatment of allergic reactions.
REFERENCES:
patent: 3980790 (1976-09-01), Hester, Jr.
patent: 3987052 (1976-10-01), Hester, Jr.
patent: 4350695 (1982-09-01), Westwood et al.
patent: 4539332 (1985-09-01), Biftu et al.
patent: 4595693 (1987-06-01), Biftu et al.
patent: 4621094 (1986-11-01), Findlay et al.
Science vol. 226, Platelet-Activating Factor-Induced of Human Platelets Specifically Inhibited by Trizolobenzodiazepines Sep. 28, 1984, pp. 1454-1455.
Touvay et al. Oral effects of BN1267, A novel Peripheral Antihistamic compound on Antigen-OR PAF-Acether . . . (1986) p. 194 (6th International Conf.).
Piwinski et al. Chap. 8 Pulmonary & Antiallergy Agents (1978).
Boxer Matthew
Cintins Marianne M.
Jeanette Henry C.
Schering Corporation
Weddington K.
LandOfFree
Certain PAF antagonist antihistamine combinations and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain PAF antagonist antihistamine combinations and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain PAF antagonist antihistamine combinations and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-64968